L2HGDH
L-2-hydroxyglutarate dehydrogenase, mitochondrial
Also known as: C14orf160, FLJ12618, L2HDH_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H9P8
- Gene
- L2HGDH
- Ensembl
- ENSG00000087299
- Chromosome
- 14
- Canonical length
- 463 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This gene encodes L-2-hydroxyglutarate dehydrogenase, a FAD-dependent enzyme that oxidizes L-2-hydroxyglutarate to alpha-ketoglutarate in a variety of mammalian tissues. Mutations in this gene cause L-2-hydroxyglutaric aciduria, a rare autosomal recessive neurometabolic disorder resulting in moderate to severe cognitive disability. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
463 residues, UniProt reviewed canonical sequence.
>Q9H9P8|L2HGDH
1 MVPALRYLVG ACGRARGLFA GGSPGACGFA SGRPRPLCGG SRSASTSSFD IVIVGGGIVG
61 LASARALILR HPSLSIGVLE KEKDLAVHQT GHNSGVIHSG IYYKPESLKA KLCVQGAALL
121 YEYCQQKGIS YKQCGKLIVA VEQEEIPRLQ ALYEKGLQNG VPGLRLIQQE DIKKKEPYCR
181 GLMAIDCPHT GIVDYRQVAL SFAQDFQEAG GSVLTNFEVK GIEMAKESPS RSIDGMQYPI
241 VIKNTKGEEI RCQYVVTCAG LYSDRISELS GCTPDPRIVP FRGDYLLLKP EKCYLVKGNI
301 YPVPDSRFPF LGVHFTPRMD GSIWLGPNAV LAFKREGYRP FDFSATDVMD IIINSGLIKL
361 ASQNFSYGVT EMYKACFLGA TVKYLQKFIP EITISDILRG PAGVRAQALD RDGNLVEDFV
421 FDAGVGDIGN RILHVRNAPS PAATSSIAIS GMIADEVQQR FELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against L2HGDH can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 18 nTPM
Expression across tissuesHPA
Tissue
- kidney: 18 nTPM
- skeletal muscle: 15 nTPM
- tongue: 14 nTPM
- liver: 12 nTPM
- retina: 9.9 nTPM
- parathyroid gland: 5.8 nTPM
Single-cell type
- cone photoreceptor cells: 211 nCPM
- rod photoreceptor cells: 157 nCPM
- proximal tubule cells: 118 nCPM
- myonuclei: 105 nCPM
- renal connecting tubule cells: 87 nCPM
- retinal ganglion cells: 85 nCPM
Immune cell
- basophil: 8.7 nTPM
- MAIT T-cell: 2.2 nTPM
- naive CD8 T-cell: 1.7 nTPM
- NK-cell: 1.7 nTPM
- T-reg: 1.6 nTPM
- naive CD4 T-cell: 1.3 nTPM
Brain region
- cerebellum: 23 nTPM
- cerebral cortex: 21 nTPM
- basal ganglia: 17 nTPM
- white matter: 17 nTPM
- hypothalamus: 16 nTPM
- midbrain: 16 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about L2HGDH.
Disease | AllUniProt
Conditions L2HGDH is implicated in, by any mechanism.
- L-2-hydroxyglutaric aciduria (L2HGA) MIM:236792
Disease | GeneticClinVar
45 pathogenic / likely-pathogenic of 334 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- L-2-hydroxyglutaric aciduria
- L2HGDH-related disorder
- Abnormality of metabolism/homeostasis
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.79
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.42
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 2-oxoglutarate metabolic process
- small molecule metabolic process
Molecular functions
- (S)-2-hydroxyglutarate dehydrogenase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads L2HGDH as an antibody target. Whether an autoantibody or antibody against L2HGDH could matter depends on whether native L2HGDH is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
L2HGDH is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label L2HGDH as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...